NASDAQ: NKTX

Nkarta Inc Stock Forecast, Predictions & Price Target

The consensus among 5 Wall Street analysts covering (NASDAQ: NKTX) stock is to Strong Buy NKTX stock.

Out of 5 analysts, 2 (40%) are recommending NKTX as a Strong Buy, 3 (60%) are recommending NKTX as a Buy, 0 (0%) are recommending NKTX as a Hold, 0 (0%) are recommending NKTX as a Sell, and 0 (0%) are recommending NKTX as a Strong Sell.

If you're new to stock investing, here's how to buy Nkarta stock.

(NASDAQ: NKTX) Nkarta's forecast annual revenue growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 37.04%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 9.92%.

Nkarta's revenue in 2024 is $0.On average, 1 Wall Street analysts forecast NKTX's revenue for 2026 to be $7,412,427,900, with the lowest NKTX revenue forecast at $7,412,427,900, and the highest NKTX revenue forecast at $7,412,427,900. On average, 2 Wall Street analysts forecast NKTX's revenue for 2027 to be $1,761,687,031, with the lowest NKTX revenue forecast at $410,154,344, and the highest NKTX revenue forecast at $3,113,219,718.

In 2028, NKTX is forecast to generate $5,638,238,574 in revenue, with the lowest revenue forecast at $545,554,693 and the highest revenue forecast at $11,155,703,990.

According to 5 Wall Street analysts that have issued a 1 year NKTX price target, the average NKTX price target is $18.80, with the highest NKTX stock price forecast at $25.00 and the lowest NKTX stock price forecast at $15.00.

On average, Wall Street analysts predict that Nkarta's share price could reach $18.80 by Apr 10, 2025. The average Nkarta stock price prediction forecasts a potential upside of 175.66% from the current NKTX share price of $6.82.

(NASDAQ: NKTX) forecast ROE is N/A, which is considered weak.